Lack of neurofibromatosis type 2 gene promoter methylation in sporadic vestibular schwannomas

ORL

Volumn 74, Issue 1, 2012, Pages 33-37

  Koutsimpelas, D ^a   Ruerup, G ^a   Mann, W J ^a   Brieger, J ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Acoustic neuroma; Methylation specific polymerase chain reaction; Neurofibromatosis

Indexed keywords

GENOMIC DNA;

ACOUSTIC NEURINOMA; ADULT; AGED; ARTICLE; BENIGN TUMOR; CLINICAL ARTICLE; DNA METHYLATION; FEMALE; GENE MUTATION; GENE PRODUCT; HUMAN; MALE; METHYLATION SPECIFIC POLYMERASE CHAIN REACTION; NEUROFIBROMATOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION;

ADULT; AGED; DISEASE PROGRESSION; DNA METHYLATION; DNA, NEOPLASM; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MUTATION; NEUROFIBROMIN 2; NEUROMA, ACOUSTIC; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84855793928     PISSN: 03011569     EISSN: 14230275     Source Type: Journal    
DOI: 10.1159/000334968     Document Type: Article

References (23)

1. Charabi S, Tos M, Thomsen J, Charabi B, Mantoni M: Vestibular schwannoma growth: The continuing controversy. Laryngoscope 2000; 110: 1720-1725.
2. Irving RM, Moffat DA, Hardy DG, Barton DE, Xuereb JH, Maher ER: Somatic NF2 gene mutations in familial and non-familial vestibular schwannoma. Hum Mol Genet 1994; 3: 347-350. (Pubitemid 24060955)
3. Stemmer-Rachamimov AO, Xu L, Gonzalez-Agosti C, Burwick JA, Pinney D, Beauchamp R, Jacoby LB, Gusella JF, Ramesh V, Louis DN: Universal absence of merlin, but not other ERM family members, in schwannomas. Am J Pathol 1997; 151: 1649-1654. (Pubitemid 27527927)
4. Rouleau GA, Merel P, Lutchman M, Sanson M, Zucman J, Marineau C, Hoang-Xuan K, Demczuk S, Desmaze C, Plougastel B, Pulst SM, Lenoir G, Bijlsma E, Fashold R, Dumanski J, de Jong P, Parry D, Eldrige R, Aurias A, Delattre O, Thomas G: Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 1993; 363: 515-521. (Pubitemid 23186636)
5. Xiao GH, Chernoff J, Testa JR: NF2: The wizardry of merlin. Genes Chromosomes Cancer 2003; 38: 389-399. (Pubitemid 37466941)
6. Bai Y, Liu YJ, Wang H, Xu Y, Stamenkovic I, Yu Q: Inhibition of the hyaluronan-CD44 interaction by merlin contributes to the tumor-suppressor activity of merlin. Oncogene 2007; 26: 836-850.
7. Pelton PD, Sherman LS, Rizvi TA, Marchionni MA, Wood P, Friedman RA, Ratner N: Ruffling membrane, stress fiber, cell spreading and proliferation abnormalities in human Schwannoma cells. Oncogene 1998; 17: 2195-2209. (Pubitemid 28515373)
8. Rosenbaum C, Kluwe L, Mautner VF, Friedrich RE, Müller HW, Hanemann CO: Isolation and characterization of Schwann cells from neurofibromatosis type 2 patients. Neurobiol Dis 1998; 5: 55-64. (Pubitemid 28361652)
9. Utermark T, Kaempchen K, Antoniadis G, Hanemann CO: Reduced apoptosis rates in human schwannomas. Brain Pathol 2005; 15: 17-22. (Pubitemid 40224062)
10. Schulze KM, Hanemann CO, Müller HW, Hanenberg H: Transduction of wild-type merlin into human schwannoma cells decreases schwannoma cell growth and induces apoptosis. Hum Mol Genet 2002; 11: 69-76. (Pubitemid 34100769)
11. Antinheimo J, Sallinen SL, Sallinen P, Haapasalo H, Helin H, Horelli-Kuitunen N, Wessman M, Sainio M, Jääskeläinen J, Carpén O: Genetic aberrations in sporadic and neurofibromatosis 2 (NF2)-associated schwannomas studied by comparative genomic hybridization (CGH). Acta Neurochir 2000; 142: 1099-1105.
12. Gardiner-Garden M, Frommer M: CpG islands in vertebrate genomes. J Mol Biol 1987; 196: 261-282. (Pubitemid 17122132)
13. Esteller M: Epigenetics in cancer. N Engl J Med 2008; 358: 1148-1159.
14. Kino T, Takeshima H, Nakao M, Nishi T, Yamamoto K, Kimura T, Saito Y, Kochi M, Kuratsu J, Saya H, Ushio Y: Identification of the cis -acting region in the NF2 gene promoter as a potential target for mutation and methylation-dependent silencing in schwannoma. Genes Cells 2001; 6: 441-454. (Pubitemid 32487455)
15. Gonzalez-Gomez P, Bello MJ, Alonso ME, Lomas J, Arjona D, Campos JM, Vaquero J, Isla A, Lassaletta L, Gutierrez M, Sarasa JL, Rey JA: CpG island methylation in sporadic and neurofibromatis [sic!] type 2-associated schwannomas. Clin Cancer Res 2003; 9: 5601-5606. (Pubitemid 37499480)
16. Kullar PJ, Pearson DM, Malley DS, Collins VP, Ichimura K: CpG island hypermethylation of the neurofibromatosis type 2 (NF2) gene is rare in sporadic vestibular schwannomas. Neuropathol Appl Neurobiol 2010; 36: 505-514.
17. Herman JG, Graff JR, Myöhänen S, Nelkin BD, Baylin SB: Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996; 93: 9821-9826. (Pubitemid 26296693)
18. Warren C, James LA, Ramsden RT, Wallace A, Baser ME, Varley JM, Evans DG: Identification of recurrent regions of chromosome loss and gain in vestibular schwannomas using comparative genomic hybridisation. J Med Genet 2003; 40: 802-806. (Pubitemid 37485489)
19. Jacoby LB, MacCollin M, Barone R, Ramesh V, Gusella JF: Frequency and distribution of NF2 mutations in schwannomas. Genes Chromosomes Cancer 1996; 17: 45-55. (Pubitemid 26327934)
20. Koutsimpelas D, Felmeden U, Mann WJ, Brieger J: Analysis of cytogenetic aberrations in sporadic vestibular schwannoma by comparative genomic hybridization. J Neurooncol 2010; 103: 437-443.
21. Buckley PG, Mantripragada KK, Díaz de Stahl T, Piotrowski A, Hansson CM, Kiss H, Vetrie D, Ernberg IT, Nordenskjöld M, Bolund L, Sainio M, Rouleau GA, Niimura M, Wallace AJ, Evans DG, Grigelionis G, Menzel U, Dumanski JP: Identification of genetic aberrations on chromosome 22 outside the NF2 locus in schwannomatosis and neurofibromatosis type 2. Hum Mutat 2005; 26: 540-549. (Pubitemid 41780476)
22. Díaz-Cano SJ, Brady SP: NA extraction from formalin-fixed, paraffin-embedded tissues: Protein digestion as a limiting step for retrieval of high-quality DNA. Diagn Mol Pathol 1997; 6: 342-346. (Pubitemid 28175934)
23. Hamilton MG, Roldán G, Magliocco A, Mc-Intyre JB, Parney I, Easaw JC: Determination of the methylation status of MGMT in different regions within glioblastoma multiforme. J Neurooncol 2011; 102: 255-260.